The Future of Genomic Sequencing

Illumina is the dominant force behind bringing the cost of genomic sequencing down. Garden Health came out public maybe last year and they're doing the liquid biopsy that maybe they're not in really the genomic health without. There are companies like exact sciences that have colon cancer test that's basically helped you get around the colonoscopy. And then on the precision medicine, you have to think about the so-called CRISPR stocks,.